96849 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
RIBONUCLEASE ACTIVITY REGULATOR PROTEIN VARIANT AND METHOD OF PRODUCING L-VALINE USING THE SAME
#2ANTI-CRISPR DELIVERY COMPOSITIONS AND METHODS
#3DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE
#4METHOD FOR SECRETORY PRODUCTION OF PROTEINS
#5BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
#6CRM197 PROTEIN EXPRESSION METHOD
#7AUTOMATED PERIPLASMIC EXTRACTION
#8CYTOTOXIN-CCL8 PEPTIDE CONSTRUCTS AND USES THEREOF
#9E. COLI FOR THE PRODUCTION OF DIPHTHERIA TOXIN POLYPEPTIDES
#10METHOD FOR PRODUCING A PERIPLASMIC FORM OF THE PROTEIN CRM197
#11GLXR PROTEIN VARIANT OR THREONINE PRODUCTION METHOD USING SAME
#12NOVEL GLUTAMATE GLUCONATE REPRESSOR VARIANT AND METHOD FOR PRODUCING L-ARGININE USING SAME
#13NOVEL VARIANT REGULATOR OF ACETATE METABOLISM A AND METHOD OF PRODUCING L-BRANCHED-CHAIN AMINO ACID USING THE SAME
#14RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_09525 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF
#15IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER
#16LYSE VARIANT AND METHOD FOR PRODUCING L-ARGININE BY USING SAME
#17DIPHTHERIA-BASED INTRANEURAL DELIVERY VEHICLES AND PRODUCTION PROCESSES THEREOF
#18RECOMBINANT MICROORGANISM, METHOD FOR CONSTRUCTING SAME AND USE THEREOF
#19MICROORGANISM HAVING WEAKENED ACTIVITY OF LACI FAMILY DNA-BINDING TRANSCRIPTIONAL REGULATOR, AND L-GLUTAMIC ACID PRODUCTION METHOD USING SAME
#20STRAIN FOR PRODUCING HIGH CONCENTRATION L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME
#21CONJUGATED VACCINE CARRIER PROTEINS
#22RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_04920 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF
#23Compositions and Methods for Killing PD-1 Positive Cells
#24Method for the fermentative production of L-lysine using strains expressing modified gluconate repressor proteins GntR1 and GntR2
#25COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS
#26Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
#27IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY
#28MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
#29Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#30RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_14900, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF
#31Vaccines targeting Pseudomonas aeruginosa
#32RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_11265 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF
#33STRAIN HAVING ENHANCED L-GLUTAMIC ACID PRODUCTIVITY, CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF
#34Hepatitis C virus immunogenic compositions and methods of use thereof
#35PROTEIN HAVING L-PROLINE EFFLUX FUNCTION, AND USE THEREOF
#36PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOF
#37Compositions and methods for the encapsulation and scalable delivery of agrochemicals
#38deficient in Lon and SulA for gene targeting
#39RECOMBINANT STRAIN FOR PRODUCING L-AMINO ACID AND CONSTRUCTION METHOD AND USE THEREOF
#40Modified Antibody
#41RECOMBINANT STRAIN PRODUCING L-LYSINE AND CONSTRUCTION METHODS THEREFOR AND USE THEREOF
#42Reduced genome lacking toxin-antitoxin genes
#43NOVEL L-TYROSINE-EXPORTING PROTEIN VARIANT AND METHOD FOR PRODUCING L-TYROSINE USING THE SAME
#44IMMUNOGENIC COMPOSITIONS
#45Microorganism that produces lysine and method for producing lysine
#46Polypeptide and method of producing IMP using the same
#47NOVEL ACETOHYDROXY ACID SYNTHASE VARIANT AND MICROORGANISM INCLUDING THE SAME
#48Glycoconjugation process
#49Polypeptide and method of producing IMP using the same
#50Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#51MUTANT OF CORYNEBACTERIUM GLUTAMICUM WITH ENHANCED L-GLUTAMIC ACID PRODUCTIVITY AND METHOD FOR PREPARING L-GLUTAMIC ACID USING THE SAME
#52IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6
#53BIVALENT EGF FUSION TOXINS
#54MICROORGANISMS WITH ENHANCED L-BRANCHED-CHAIN AMINO ACIDS PRODUCTIVITY AND METHOD FOR PRODUCING L-BRANCHED-CHAIN AMINO ACIDS USING THE SAME
#55MICROORGANISM COMPRISING VARIANT LYSE AND METHOD OF L-AMINO ACID PRODUCTION USING SAME
#56Modified Antibody
#57Adeno-Associated Viral (AAV) Vectors for Tissue-Targeted Expression of Therapeutic Genes
#58CRM197 protein expression
#59Microorganism producing purine nucleotide and method of producing purine nucleotide using the same
#60Polypeptide and method of producing IMP using the same
#61PRODUCTION OF BACTERIOCINS
#62Method of producing sulfur-containing amino acid or derivative thereof
#63METHOD OF PRODUCING SULFUR-CONTAINING AMINO ACID OR DERIVATIVE THEREOF
#64FUSION PROTEINS AND USES THEREOF
#65CRM197 PROTEIN EXPRESSION METHOD
#66Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#67COMPOSITIONS AND METHODS FOR TREATMENT OF DISTENTABLE TISSUES
#68MICROORGANISM WITH ENHANCED L-HISTIDINE PRODUCTION CAPACITY AND METHOD FOR PRODUCING HISTIDINE BY USING SAME
#69METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES
#70MICROORGANISM HAVING ENHANCED L-THREONINE PRODUCING ABILITY AND METHOD FOR PRODUCING THREONINE USING THE SAME
#71BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
#72RamA transcription factor mutant for promoting production of N-acetylglucosamine and use thereof
#73Transcription factor SugR coding gene, and use thereof in production of N-acetylglucosamine
#74MODIFIED CARRIER PROTEINS FOR O-LINKED GLYCOSYLATION
#75Tetanus toxoid and CCL3 improve DC vaccines
#76Polypeptide and method of producing IMP using the same
#77Multi-level specific targeting of cancer cells
#78Glycoconjugation process
#79Production of soluble recombinant proteins without N-terminal methionine in
#80Immunotoxin for treating cancer
#81Recombinant having 1,3-PDO productivity and reduced 3-HP productivity, and method for producing 1,3-PDO by using same
#82Hepatitis C virus immunogenic compositions and methods of use thereof
#83METHODS AND KITS FOR IDENTIFYING A PROTEIN ASSOCIATED WITH RECEPTOR-LIGAND INTERACTIONS
#84Microorganism of genus producing L-arginine and method for producing L-arginine using the same
#85Immunotoxin for treating cancer
#86METHOD FOR EFFICIENTLY RECOVERING AND PURIFYING ACTIVE CRM197 FROM INSOLUBLE CRM197 PROTEIN EXPRESSED IN INCLUSION BODY
#87METHOD FOR SECRETORY PRODUCTION OF PROTEIN
#88Split-immunotoxins for boosting oncolytic virus toxicity
#89Immunogenic compositions
#90Polypeptide and method of producing IMP using the same
#91Polypeptide and method of producing IMP using the same
#92Microorganism of the genus producing L-amino acids and a method for producing L-amino acids using the same
#93NUCLEIC ACID ENCODING CRM197 AND PROCESS FOR IMPROVED EXPRESSION THEREOF
#94Glycoconjugation process
#95Methods and compositions for improved expression of recombinant proteins
#96Method for high level production of CRM
#97Recombinant microorganism having enhanced ability to produce heme, coproporphyrin III, and uroporphyrin III, and method for producing heme, coproporphyrin III, and uroporphyrin III using same
#98Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#99NANOSTRUCTURED PROTEINS AND USES THEREOF
#100Systems and methods for the production of diphtheria toxin polypeptides
#101Production of soluble recombinant protein without n-terminal methionine
#102Materials and methods for extended continuous flow fermentation of reduced genome bacteria
#103Modified polypeptide having an activity of ornithine-based product exporter and method for producing ornithine-based product using cells expressing the polypeptide
#104Purification of CRM 197 from bacteria
#105Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#106METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN
#107Compositions and methods for the encapsulation and scalable delivery of agrochemicals
#108Multi-level specific targeting of cancer cells
#109Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
#110Conjugated vaccine carrier proteins
#111Method of producing 2′-fucosyllactose using recombinant
#112Method for expressing and purifying soluble protein of CRM197
#113Vaccines targeting
#114Glycoconjugation process
#115EXPRESSION SYSTEM
#116Polypeptide and method of producing IMP using the same
#117Mutant microorganism for producing L-cysteine and method for producing L-cysteine using same
#118Protein secretory production method
#119Hepatitis C virus immunogenic compositions and methods of use thereof
#120Method of producing D-xylonate and coryneform bacterium
#121Microbial-based biosensors
#122Genetic perturbation of the RNA degradosome protein complex
#123PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE
#124Methods for inhibiting hematopoietic tumor cells with diphtheria tokin-interleukin-3 conjugates
#125Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#126Multi-level specific targeting of cancer cells
#127Microorganisms for producing diamine and process for producing diamine using them
#128Method for the fermentative production of L-amino acids
#129Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#130Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#131Expression and purification of CRM proteins and related proteins, and protein domains
#132Methods for making saccharide-protein glycoconjugates
#133Corynebacterium glutamicum for use in producing 2′-fucosyllactose
#134Deimmunized therapeutic compositions and methods
#135sp. microorganisms having l-lysine-producing ability and l-lysine producing method using same
#136Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using same
#137EXPRESSION SYSTEM
#138sp. microorganisms having L-lysine-producing ability and method for producing L-lysine using same
#139PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE
#140METHOD OF SCREENING GENE FOR 1,4-BDO PRODUCTION
#141Tetanus toxoid and CCL3 improve DC vaccines
#142Microorganism producing L-lysine and method for producing L-lysine using the same
#143Gluconate repressor variant, microorganism containing the same producing L-lysine, and method for producing L-lysine
#144Method for producing L-amino acid
#145Materials and methods for extended continuous flow fermentation of reduced genome bacteria
#146Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#147Method for secretory production of protein
#148Microorganism with enhanced L-lysine producibility and method for producing L-lysine using the same
#149Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#150Compositions and methods for peptide expression and purification using a type III secretion system
#151Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
#152Method of treating a bladder cancer using a chimeric EGF-targeted bacterial toxin
#153Codon optimized polynucleotide for high level expression of CRM197
#154MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS
#155Glycan conjugates and use thereof
#156Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof
#157Polypeptide for binding to complement protein C5A, and use of same
#158Microorganism having improved L-lysine productivity and method for producing L-lysine using same
#159Expression system
#160Method for producing L-amino acid of glutamate family
#161Targeting of chondroitin sulfate glycans
#162Enhanced production of recombinant CRM197 in
#163Microorganisms for producing diamine and process for producing diamine using them
#164EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI
#165POLYPEPTIDE AND ANTI-TUMOR AGENT
#166Targeting of chondroitin sulfate glycans
#167Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
#168Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
#169Recombinant microorganisms of with L-threonine productivity and method of producing L-threonine using the same
#170Modified microbial toxin receptor for delivering agents into cells
#171microorganism with improved ability to produce L-lysine and method for producing L-lysine using the same
#172Expression and purification of CRM197 and related proteins
#173Methods for making saccharide-protein glycoconjugates
#174Tetanus toxoid and CCL3 improve DC vaccines
#175Microorganism and Method for the Fermentative Production of an Organic-Chemical Compound
#176Method for producing target substance
#177Method for producing protein by precipitation
#178Method of screening gene for 1,4-BDO production
#179EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF
#180Methods for treating cancer using an immunotoxin
#181Microorganism for methionine production with improved methionine synthase activity and methionine efflux
#182Microorganism of the genus with enhanced ability to produce L-arginine and method for producing L-arginine using the same
#183PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE
#184Coryneform bacterium and method for producing heterologous fusion proteins
#185Modified antibody
#186INTRAOCULAR ANGIOGENESIS INHIBITOR AND USES THEREOF
#187Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#188Modified toxins
#189Methods and compositions relating to CRM197
#190Glycoconjugation process
#191Method for producing L-amino acid using microorganism having increased phosphate transporter activity
#192Genetically engineered bacterial cell having enhanced activity of GlnD or GlnK and method of producing organic acid by using the same
#193MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY
#194Compositions and methods for peptide expression and purification using a type III secretion system
#195Multi-level specific targeting of cancer cells
#196DEVELOPMENT OF THE SOLUBLE RECOMBINANT CRM197 PRODUCTION BY E. COLI
#197Conjugates for the Prevention or Treatment of Nicotine Addiction
#198MICROORGANISM WITH INCREASED IRON-REGULATED ABC TRANSPORTER ACTIVITY AND METHOD OF PRODUCING HYDROXYCARBOXYLIC ACID BY USING THE MICROORGANISM
#199Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4)
#200Genes encoding biofilm formation inhibitory proteins and a method for producing L-lysine using a bacterial strain with the inactivated genes
#201COMPOSITION
#202COMPOSITIONS
#203HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway
#204Targeting of chondroitin sulfate glycans
#205Methods for making saccharide-protein glycoconjugates
#206Vectors harboring toxic genes, methods and uses therefor
#207Method for secretory production of protein
#208Method for secretory production of protein
#209Method for secretory production of protein
#210Methods for treating cancer using an immunotoxin
#211Promoter of Corynebacteria
#212Processes and recombinant microorganisms for the production of cadaverine
#213Process for preparing L-amino acids
#214Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
#215Method for producing an L-amino acid belonging to the glutamate family, using a coryneform bacterium
#216High level expression of recombinant toxin proteins
#217Fermentation process
#218Modified microorganism for high efficient production of 1,4-butanediol
#219Microorganisms for producing putrescine and method for producing putrescine using same
#220Microorganisms having improved ornithine-producing ability and method for producing ornithine using the same
#221OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE
#222Conjugation process
#223Purification of Diphtheria Toxoid
#224Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#225Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy
#226Immunotoxin fusion proteins and means for expression thereof
#227Compounds useful for multi-level specific targeting of cancer cells
#228Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer
#229Method of producing the polypeptide for treating virus-induced cancer
#230Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
#231Expression system
#232ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI
#233Process for producing dipeptides or dipeptide derivatives
#234Microorganism and method for the fermentative production of an organic-chemical compound
#235Compositions and methods for treating bladder cancer
#236Modified antibody
#237Diphtheria toxin variant
#238BACTERIAL EXPRESSION OF AN ARTIFICIAL GENE FOR THE PRODUCTION OF CRM197 AND ITS DERIVATIVES
#239CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS
#240Expression of triple-helical collagen-like products in
#241Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines
#242POLYPEPTIDE CARRIER PROTEIN
#243MIR-21 promoter driven targeted cancer therapy
#244PROCESS FOR PRODUCING USEFUL SUBSTANCE
#245Conjugates for the prevention or treatment of nicotine addiction
#246Multi-level specific targeting of cancer cells with IL-13
#247High level expression of recombinant toxin proteins
#248Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
#249Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
#250Process for producing useful substance
#251Method for producing methionine using a microorganism with reduced expression activity of a negative regulator of methionine biosynthesis
#252L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
#253NUCLEIC ACID MOLECULE AND METHOD OF TARGETING GENE EXPRESSION TO GLIOMAS
#254Production of diphtheria toxin
#255Immunotoxin fusion proteins and means for expression thereof
#256Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from
#257Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#258System and method for identifying complex patterns of amino acids
#259L-lysine-producing corynebacteria and process for the preparation of L-lysine
#260Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method
#261Methods for treating cancer using an immunotoxin
#262REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES
#263REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR
#264Group B polypeptides nucleic acids and therapeutic compositions and vaccines thereof
#265Vaccines against influenza virus
#266Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
#267L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
#268Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
#269L-lysine-inducible promoter
#270Microorganisms with Deregulated Vitamin B12 System
#271Alleles of the zwf gene from coryneform bacteria
#272Process for preparing L-amino acids
#273Pharmaceutical use of protein molecules immunologically correlated to diptheria toxin
#274Constructs for delivery of therapeutic agents to neuronal cells
#275REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS
#276L-glutamic acid producing bacterium and a method for production of L-glutamic acid
#277Pgro expression units
#278Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
#279Polypeptide carrier protein
#280L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
#281Modified toxins
#282Use of a bacillus meti gene to improve methionine production in microorganisms
#283Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#284P2-10 expression units
#285Diphtheria toxin variant
#286REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE
#287RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-XL FUSION PROTEIN INHIBITS APOPTOSIS
#288Modified toxins
#289Corynebacterium glutamicum genes encoding novel proteins
#290MODIFIED DIPHTHERIA TOXINS
#291P19 Expression Units
#292P1-35 Expression Units
#293Viral/bacterial toxin polypeptides and methods of using same
#294Use of the repressor glxR for the synthesis of lysine in corynebacterium glutamicum
#295Replikins and methods of identifying replikin-containing sequences
#296Multiple promoters and the use thereof for gene expression
#297Alleles of the oxyR gene from coryneform bacteria
#298Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers
#299Bacterial pheromones and uses thereof
#300Fermentation Process for the Production of Diphtheria Toxin